Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Immunotherapy × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Thoracic 16 Gastrointestinal 11 Head & Neck 4 Dermatologic 4 Tumor-Agnostic 3 Breast 3 Genitourinary 2 Plasma cell 1 Lymphoid 1 CNS 1

Conditions

Multiple Myeloma 1

Interventions

Bortezomib 20 Surveys and Questionnaires 8 Lenalidomide 7 Dexamethasone 7 Blood Specimen Collection 7 Flow Cytometry 6 daratumumab 5 pomalidomide 4 plerixafor 4 idecabtagene vicleucel 4 carfilzomib 4 Standard of Care 4 Polymerase Chain Reaction 4 Immunoenzyme Techniques 4 Biopsy 4 Specimen Handling 3 Microarray Analysis 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Data Collection 3 Cytogenetic Analysis 3 Amplified Fragment Length Polymorphism Analysis 3 talquetamab 2 selinexor 2 belantamab mafodotin 2 Watchful Waiting 2 Reverse Transcriptase Polymerase Chain Reaction 2 Observation 2 Immunologic Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06205823 2024-01-16

CAREMM-2305

Seoul St. Mary's Hospital

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡